Clinical Trials Logo

Clinical Trial Summary

Investigators will collect blood specimens from the participating patients and then blood samples will be centrifuged in order to collect platelet-rich plasma which is going to be injected in the atrophic acne scars. A split-face design is going to used in this randomized controlled trial. In the control side of the face, micro-needling to the skin will occur using a specific tool (Dermapen).


Clinical Trial Description

Atrophic acne scar is a common problem with a challenging treatment. Platelet-rich plasma (PRP) is an autologous preparation of platelets in concentrated plasma that may be beneficial in the treatment of atrophic acne scars by promoting collagen deposition.

Skin needling is a technique that uses a sterile micro needles to puncture the skin and release growth factors. The combination of skin needling and PRP could enhance the efficacy of both modalities. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02798016
Study type Interventional
Source Damascus University
Contact
Status Completed
Phase N/A
Start date October 2015
Completion date October 20, 2017

See also
  Status Clinical Trial Phase
Completed NCT02643628 - A Pilot Study to Evaluate the Safety and Effectiveness of Microneedling and Bellafill to Treat Facial Acne Scars N/A
Recruiting NCT05995340 - ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars Phase 3
Active, not recruiting NCT01773343 - Treatment of Atrophic Acne Scars With a Fractional CO2 Laser at 1 Versus 3 Months Intervals N/A
Completed NCT02145364 - Ultherapy® for the Treatment of Acne Scars N/A
Completed NCT02735421 - Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars Phase 4
Completed NCT05028283 - Treatment of Atrophic Post Acne Scars by Fat Grafting N/A
Completed NCT06002854 - Comparison Of Outcome Of Microneedling With Autologous PRP Vs Microneedling With Topical Insulin In Treatment Of Post Acne Atrophic Scars. Phase 2